Compass Therapeutics (CMPX)

Compass Therapeutics LLC • Compass Therapeutics Advisors Inc. • BBV International Compass Inc. • Biomatics – Compass, Inc. • CHI II Blocker LLC • OrbiMed Private Investments V – KA (Blocker), Inc. ...

CMPX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

12 Nov 24

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update

12 Nov 24

EFFECT

Notice of effectiveness

Submission of Matters to a Vote of Security Holders

17 Jun 24

DEFA14A

Additional proxy soliciting materials

28 May 24

8-K

Compass Therapeutics Announces CEO Transition

13 May 24

Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update

13 May 24

ARS

2023 FY

Annual report to shareholders

29 Apr 24

Latest ownership filings

View all

JANUS HENDERSON GROUP PLC

Financial summary

Financial statements Chart CMPX financial data

Quarter (USD)	Sep 24	Mar 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	36.80 mm	36.80 mm	36.80 mm	36.80 mm	36.80 mm	36.80 mm
Cash burn (monthly)	(no burn)	(no burn)	4.08 mm	4.36 mm	(no burn)	2.67 mm
Cash used (since last report)	n/a	n/a	11.49 mm	12.28 mm	n/a	7.52 mm
Cash remaining	n/a	n/a	25.31 mm	24.52 mm	n/a	29.28 mm
Runway (months of cash)	n/a	n/a	6.2	5.6	n/a	11.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

CMPX institutional ownership history Ownership history

82.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	84	67	+25.4%
Opened positions	27	21	+28.6%
Closed positions	10	10	–
Increased positions	26	14	+85.7%
Reduced positions	16	22	-27.3%

13F shares	Current	Prev Q	Change
Total value	93.03 bn	86.12 bn	+8.0%
Total shares	105.05 mm	55.93 mm	+87.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Orbimed Advisors	22.36 mm	$22.36 bn	NEW
Adage Capital Partners GP, L.L.C.	11.13 mm	$11.13 bn	0.0%
Commander Aggregator	7.79 mm	$31.15 mm	0.0%
BX Blackstone	7.69 mm	$7.69 bn	NEW
BLK BlackRock	6.61 mm	$6.61 bn	+9.6%
Rock Springs Capital Management	5.51 mm	$5.51 bn	0.0%
JHG Janus Henderson	5.22 mm	$5.76 bn	NEW
MPM Oncology Impact Management	5.01 mm	$5.01 bn	NEW
Foresite Capital Fund V	4.40 mm	$0.00	0.0%
Vanguard	4.19 mm	$4.19 bn	+1.0%

Largest transactions	Shares	Bought/sold	Change
Orbimed Advisors	22.36 mm	+22.36 mm	NEW
BX Blackstone	7.69 mm	+7.69 mm	NEW
JHG Janus Henderson	5.22 mm	+5.22 mm	NEW
MPM Oncology Impact Management	5.01 mm	+5.01 mm	NEW
Blue Owl Capital	2.83 mm	+2.83 mm	NEW
Cormorant Asset Management	2.03 mm	+2.03 mm	NEW
Baker Bros. Advisors	1.56 mm	+1.56 mm	NEW
BLK BlackRock	6.61 mm	+581.17 k	+9.6%
Millennium Management	433.76 k	+433.76 k	NEW
FMR	4.13 mm	-384.76 k	-8.5%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CMPX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
9 Dec 24	Shin Barry	Common Stock	Grant	Acquire A	No	No	1.65	400,000	660.00 k	400,000
9 Dec 24	Shin Barry	Stock Option Common Stock	Grant	Acquire A	No	No	1.65	400,000	660.00 k	400,000
8 Mar 24	James P Boylan	Stock Option Common Stock	Grant	Acquire A	No	No	1.96	40,000	78.40 k	40,000
9 Feb 24	Mary Ann Gray	Stock Option Common Stock	Grant	Acquire A	No	No	1.57	40,000	62.80 k	40,000